Nanobiotix Announces Updated Voting Rights and Share Capital

Paris-based Nanobiotix, listed on both Euronext Paris and Nasdaq, has released a statement detailing its updated voting rights and share capital as of January 31, 2026. The company reports a total of 48,450,358 shares outstanding. The theoretical voting rights stand at 50,153,460, while the exercisable voting rights are slightly lower at 50,131,342. This update follows compliance with article L.233-8 II of the French Commercial Code and article 223-16 of the General Regulation of the Autorité des Marchés Financiers (AMF).

The company highlights the importance of making these figures available to ensure transparency in shareholding and voting rights. This announcement aligns with Nanobiotix's ongoing commitment to providing reliable and accurate information to its stakeholders and the broader financial markets.